Generate a tailored SOP for Dr. Peter Mol. Improve your application with a focused, well-structured draft.
Peter Mol is a professor of drug regulatory science at the University of Groningen. With substantial expertise in regulatory science, he serves as a Dutch member of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) and holds the role of clinical assessor for the Dutch Medicines Evaluation Board. His professional contributions extend to being the vice-chair of the Scientific Advice Working Party at the EMA since July 2024. Mol's academic work focuses on the intersection of science and regulatory frameworks, enhancing the understanding and evaluation of medicinal products. His significant influence in the field is underscored by his involvement in critical discussions and developments concerning medicinal product regulations in Europe.
Standard Master's entry requirements for Economics, Business, Finance, Accounting, and Management departments within the Faculty of Economics and Business.